Corvus Pharmaceuticals, Inc.
NASDAQ:CRVS
5.48 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| -27.029 | -41.307 | -43.241 | -5.995 | -46.672 | -46.939 | -55.663 | -36.375 | -31.335 | -0.176 |
| Depreciation & Amortization
| 0.151 | 0.367 | 0.46 | 0.632 | 0.743 | 0.847 | 0.842 | 0.594 | 0.148 | 0 |
| Deferred Income Tax
| -0.111 | 0 | 0 | 0 | 0 | 0 | 0 | -3.828 | -0.041 | 0 |
| Stock Based Compensation
| 2.147 | 2.692 | 4.232 | 5.747 | 7.348 | 7.135 | 6.229 | 3.828 | 0.428 | 0 |
| Change In Working Capital
| -3.594 | 1.412 | -3.236 | 1.909 | 1.904 | -1.423 | 2.575 | 3.448 | 1.832 | 0.009 |
| Accounts Receivables
| 0.562 | -0.081 | -0.507 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -0.451 | 0.411 | -1.902 | 1.019 | 0.45 | -1.456 | 1.554 | 0.518 | 1.24 | 0 |
| Other Working Capital
| -3.705 | 1.082 | -0.827 | 0.89 | 1.454 | 0.033 | 1.021 | 2.93 | 0.592 | 0.009 |
| Other Non Cash Items
| 4.501 | 9.813 | 5.07 | -37.071 | -0.644 | -0.608 | -0.195 | 4.476 | 17.64 | 0.062 |
| Operating Cash Flow
| -23.935 | -27.023 | -36.715 | -34.778 | -37.321 | -40.988 | -46.212 | -27.857 | -11.328 | -0.105 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| -0.034 | -0.269 | -0.005 | -0.076 | -0.025 | -0.355 | -0.266 | -2.199 | -1.747 | 0 |
| Acquisitions Net
| -0.016 | 0.022 | -0.022 | -0.045 | -0.003 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -47.048 | -66.191 | -9.357 | -42.54 | -138.586 | -161.861 | -88.309 | -258.281 | -104.385 | 0 |
| Sales Maturities Of Investments
| 62.623 | 43.162 | 30.922 | 87.385 | 141.866 | 132.024 | 173.401 | 217.924 | 14.1 | 0 |
| Other Investing Activites
| 0.016 | -0.023 | 0.022 | 0.045 | 0.003 | -29.837 | 85.092 | -40.357 | -90.285 | 0 |
| Investing Cash Flow
| 15.541 | -23.276 | 21.56 | 44.769 | 3.255 | -30.192 | 84.826 | -42.556 | -92.032 | 0 |
| Financing Activities: | ||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 7.855 | 0 | 62.158 | 1.222 | 0.024 | 64.877 | 0.711 | 71.358 | 94.948 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 7.855 | 0 | 62.158 | 0.088 | 0 | 0.393 | 0.731 | 71.358 | 94.948 | 13.76 |
| Financing Cash Flow
| 7.855 | 0 | 62.158 | 1.31 | 0.024 | 65.27 | 1.442 | 71.358 | 94.948 | 13.76 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -0.539 | -50.299 | 47.003 | 11.301 | -34.042 | -5.91 | 40.056 | 0.945 | -8.412 | 13.655 |
| Cash At End Of Period
| 12.62 | 13.159 | 63.458 | 16.455 | 5.154 | 39.196 | 45.106 | 5.05 | 4.105 | 13.655 |